Crypto startup Saturn is raising funding for an on-chain dollar product, USDat, that routes yield from Strategy’s Bitcoin-linked credit instruments into DeFi. TheCrypto startup Saturn is raising funding for an on-chain dollar product, USDat, that routes yield from Strategy’s Bitcoin-linked credit instruments into DeFi. The

Get access to Strategy’s 11% Bitcoin dividends without owning the stock through this new token

Crypto startup Saturn is raising funding for an on-chain dollar product, USDat, that routes yield from Strategy’s Bitcoin-linked credit instruments into DeFi.

The round included $500,000 from YZi Labs and a $300,000 angel raise led by Sora Ventures, as Saturn positions USDat as a dollar-denominated token whose returns are tied to Strategy’s STRC preferred equity.

STRC is a Nasdaq-listed perpetual security that currently pays an annualized dividend of 11% distributed monthly, according to Strategy.

Rather than framing USDat as a conventional yield-bearing stablecoin, Saturn is packaging public-market credit exposure into a blockchain-native format.

Saturn’s USDat turns Strategy-linked yield into a blockchain-native asset

The structure converts Strategy’s dividend-paying preferred stock into a digital asset that can be held, transferred, and eventually used within DeFi protocols.

The approach places Saturn closer to a tokenized credit wrapper than to stablecoins backed solely by short-term U.S. Treasuries.

Strategy’s STRC, branded internally as “Stretch,” is designed to trade near $100 par through monthly dividend resets, with the company adjusting payouts to stabilize secondary-market pricing.

Strategy lists the current dividend rate at 11.00% annualized, a level that stands well above prevailing cash benchmarks.

U.S. three-month Treasury bills yielded about 3.6% in mid-January 2026, according to Trading Economics.

Tokenized Treasury products tracked roughly 3.1% over seven days as of early January, according to RWA.xyz.

That gap is central to Saturn’s pitch.

The yield does not come from higher on-chain interest rates, but from exposure to Strategy’s capital structure and its ability to sustain preferred dividends through Bitcoin-backed financing and securities issuance.

In this structure, Bitcoin price volatility feeds into Strategy’s balance sheet, which supports STRC's dividends, which Saturn then channels into tokenized dollar liabilities.

Saturn’s own messaging reflects this layered design, though not always consistently.

Related Reading

Tokenized Treasuries skyrocketed 125%, creating this “programmable cash” loop that banks are scrambling to copy

Tokenized RWAs are dominated by Ethereum, but one unexpected blockchain rival just surged 28% to outpace the leader.

Jan 10, 2026 · Gino Matos

How Saturn turns Strategy exposure into tokenized yield

One Saturn explainer distinguishes between USDat, described as a liquidity-focused dollar token initially backed by tokenized U.S. Treasuries, and sUSDat, a staked variant that earns yield sourced from STRC.

At the same time, Saturn’s homepage markets USDat directly as offering “11%+ yield,” compressing the distinction between cash-like exposure and credit-backed returns.

This structure aligns with a broader shift in digital dollar markets toward differentiated tiers of risk and return.

Cash-equivalent stablecoins continue to serve payments and settlement use cases, while portfolio-backed dollar tokens introduce explicit exposure to credit, liquidity, and issuer risk.

Saturn is attempting to occupy that second category using Bitcoin-treasury-company credit as its yield engine.

The macro context makes the contrast more pronounced.

Tokenized Treasuries have grown to roughly $8.86 billion in total value, according to RWA.xyz, demonstrating rapid adoption of on-chain cash equivalents.

At the same time, stablecoins have expanded into mainstream financial plumbing.

More than $300 billion in stablecoins are now circulating globally, with Visa and other incumbents integrating stablecoin settlement into existing payment rails.

As stablecoins begin offering yield rather than just transactional utility, they increasingly intersect with products such as money-market funds, broker cash sweeps, and short-duration credit vehicles.

That convergence has drawn regulatory scrutiny, particularly around whether yield-bearing dollar tokens function as unregulated deposit substitutes.

Related Reading

Solana is becoming settlement rail for Visa and JPMorgan but one metric still scares insiders

Wyoming’s Frontier launch plus a Wall Street wrapper filing happened fast, and the real institutional bet is on settlement rails.

Jan 8, 2026 · Gino Matos

Saturn’s growth hinges on Strategy’s issuance capacity and market conditions

Saturn’s scaling ambitions are closely tied to Strategy’s issuance capacity.

Strategy’s STRC initial public offering raised about $2.47 billion and was later supplemented by a $4.2 billion at-the-market program, according to company disclosures.

While this provides several billions of potential float, it also imposes a structural ceiling on how much STRC-backed digital credit can be issued without leverage.

Reaching $10 billion in Saturn-issued liabilities would likely require a substantial share of available STRC supply, along with liquidity buffers to manage redemptions during market stress.

That dependency becomes more visible in adverse scenarios.

If Bitcoin prices fall sharply and capital markets tighten, Strategy’s ability to maintain preferred dividends through ongoing issuance could be tested.

If STRC were to trade meaningfully below par, any wrapper assuming near-par stability would face coverage pressure during redemptions unless overcollateralized.

Policy risk adds another layer of uncertainty

U.S. lawmakers just delayed progress on a crypto market-structure bill following objections from Coinbase, with draft language that could restrict interest or rewards paid on stablecoins.

Banking groups have also pushed back against yield-bearing tokens, arguing they compete with insured deposits.

Related Reading

Crypto yields expose the exact amount banks are underpaying you, and why they want Congress to ban it

Incumbents are lobbying to define crypto rewards as illegal interest because they can't afford to compete with yields that track the real government rate.

Jan 14, 2026 · Liam 'Akiba' Wright

Frameworks such as the GENIUS Act subject stablecoin issuers exceeding $10 billion in circulation to heightened federal oversight, raising questions about how products like USDat would ultimately be classified.

These pressures are likely to force design tradeoffs.

If passive yield on stablecoins becomes constrained, issuers may need to pivot toward tokenized securities, restrict distribution, or tie returns to activity rather than simple holding.

Despite those uncertainties, investors backing Saturn are framing the project as an early bridge between public-market Bitcoin credit and on-chain finance.

Sora Ventures founder Jason Fang said the firm backed Saturn because it connects institutional credit products with DeFi infrastructure in a way that existing stablecoins do not.

Saturn co-founder Kevin Li said the protocol aims to scale transparent yield distribution into the billions of dollars using Strategy’s digital credit products.

As tokenized Treasuries, payment stablecoins, and yield-bearing dollars continue to converge, Saturn’s model places public-market credit behavior, rather than DeFi mechanics alone, at the center of whether digital dollars can sustain double-digit returns at scale.

The post Get access to Strategy’s 11% Bitcoin dividends without owning the stock through this new token appeared first on CryptoSlate.

Market Opportunity
DeFi Logo
DeFi Price(DEFI)
$0.000519
$0.000519$0.000519
-1.89%
USD
DeFi (DEFI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23